OCS Liver Perfusion (OLP) Post-Approval Registry

Active, not recruitingOBSERVATIONAL
Enrollment

166

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

March 22, 2024

Study Completion Date

June 30, 2026

Conditions
Liver Transplant
Interventions
DEVICE

OCS Liver

Multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.

Trial Locations (9)

27710

Duke Medical Center, Durham

30322

Emory, Atlanta

35294

University of Alabama, Birmingham

48202

Henry Ford Hospital, Detroit

68198

University of Nebraska Medical Center, Omaha

77030

Houston Methodist, Houston

92037

University of California San Diego, La Jolla

94143

University of California San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT05074160 - OCS Liver Perfusion (OLP) Post-Approval Registry | Biotech Hunter | Biotech Hunter